Consistently, our study revealed that FRAX597 significantly inhibited PAK2 phosphorylation and effectively reduced breast cancer cell clustering, invasion, migration, and metastatic spread both in vitro and in vivo. This evidence concerns the gene PAK2 and breast carcinoma.